Correction factor testing using frequent blood glucose input
AssigneeSmiths Medical MD, Inc.
InventorsMichael Blomquist, Rhall E. Pope
Life of this patent
Estimating the term…
Loading patent…
AssigneeSmiths Medical MD, Inc.
InventorsMichael Blomquist, Rhall E. Pope
Estimating the term…
An apparatus comprising a user interface configured to generate an electrical signal to begin determination of an effective correction factor when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, and a controller in electrical communication with the input and the user interface. The controller includes a correction factor module configured for determining an effective correction factor according to an amount of insulin in the initial insulin correction bolus and a decrease in the blood glucose level determined using the sampled blood glucose data. Other devices and methods are disclosed.
An apparatus comprising:
26-47. (canceled)
An apparatus comprising:
Dependencies are inferred from the claim text.